Aromatase inhibitors and calcium absorption in early stage breast cancer.

Breast Cancer Research and Treatment
Amye TevaarwerkKaren E Hansen

Abstract

To investigate the effect of aromatase inhibitors (AI) on intestinal calcium absorption, measured using the gold-standard dual stable calcium isotope method. In this pilot study, we recruited 10 postmenopausal women with hormone receptor-positive breast cancer who planned to initiate AI therapy; women receiving chemotherapy were excluded. Women completed two 24 h inpatient calcium absorption study visits, the first prior to AI therapy and the second at least 6 weeks following onset of AI therapy. We calculated total fractional calcium absorption (TFCA) using the dose-corrected fractional recovery of two stable isotopes from 24 h urine collections. Ten postmenopausal women (mean±SD age, 66±7 years; 25(OH)D 40±7 ng/mL, and total calcium intake of 1,714±640 mg/day) exhibited no change in TFCA related to AI therapy (0.155±0.042 prior to and 0.160±0.064 following AI therapy, p=1.0). Subjects exhibited a surprisingly small decline in serum estradiol levels with AI therapy that was not statistically significant. However, there was a significant correlation between duration of AI therapy and the decline in serum estradiol levels (r=-0.65, p=0.040). In this pilot study, AI therapy did not decrease TFCA. Women with early stage breast can...Continue Reading

References

Aug 1, 1989·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R EastellB L Riggs
Aug 1, 1989·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R P HeaneyA J Moy
Dec 1, 1980·The Journal of Clinical Endocrinology and Metabolism·J C GallagherH F DeLuca
Dec 3, 1999·The American Journal of Clinical Nutrition·S A Abrams
Jul 27, 2000·Cancer Chemotherapy and Pharmacology·M DowsettR Yates
Aug 2, 2000·The American Journal of Clinical Nutrition·R L WolfL H Kuller
Jan 30, 2002·The American Journal of Clinical Nutrition·Amanda DevineRichard L Prince
Feb 1, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Jürgen GeislerPer Eystein Lønning
Mar 26, 2002·Climacteric : the Journal of the International Menopause Society·J M WishartB E Nordin
Sep 12, 2006·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J GeislerJ Paolini
Feb 28, 2008·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Karen E HansenMartin M Shafer
May 29, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M RabaglioUNKNOWN BIG 1-98 Collaborative and International Breast Cancer Study Groups
Oct 17, 2009·The Journal of Steroid Biochemistry and Molecular Biology·Jürgen Geisler, Per E Lønning
Jun 26, 2010·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Karen E HansenMartin M Shafer
Jul 14, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harold J BursteinUNKNOWN American Society of Clinical Oncology
Oct 12, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R EastellR E Coleman
Dec 2, 2010·The Journal of Clinical Endocrinology and Metabolism·A Catharine RossSue A Shapses
Feb 16, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Marco ColleoniAron Goldhirsch

❮ Previous
Next ❯

Citations

Nov 12, 2013·Journal of the Academy of Nutrition and Dietetics·Karishma RamsubeikKaren E Hansen
Apr 11, 2015·BioFactors·Ravindran Vini, Sreeharshan Sreeja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.